[{"id":"5b1440c6-3aed-45ad-8283-8af96015b462","acronym":"","url":"https://clinicaltrials.gov/study/NCT03262298","created_at":"2021-01-18T16:06:56.088Z","updated_at":"2024-07-02T16:36:34.891Z","phase":"Phase 1/2","brief_title":"Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies","source_id_and_acronym":"NCT03262298","lead_sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","biomarkers":" CD22","pipe":" | ","alterations":" CD22 positive","tags":["CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD22 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CART22"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 08/20/2017","start_date":" 08/20/2017","primary_txt":" Primary completion: 08/20/2021","primary_completion_date":" 08/20/2021","study_txt":" Completion: 08/20/2022","study_completion_date":" 08/20/2022","last_update_posted":"2021-02-09"}]